Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. [electronic resource] by
- Schwartsmann, G
- DiLeone, L P
- Horowitz, M
- Schunemann, D
- Cancella, A
- Pereira, A S
- Richter, M
- Souza, F
- da Rocha, A Brondani
- Souza, F H
- Pohlmann, P
- De Nucci, G
Producer: 20060901
In:
Investigational new drugs vol. 24
Availability: No items available.
|
|
8.
|
|
|
9.
|
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. [electronic resource] by
- Lynce, F
- Barac, A
- Geng, X
- Dang, C
- Yu, A F
- Smith, K L
- Gallagher, C
- Pohlmann, P R
- Nunes, R
- Herbolsheimer, P
- Warren, R
- Srichai, M B
- Hofmeyer, M
- Cunningham, A
- Timothee, P
- Asch, F M
- Shajahan-Haq, A
- Tan, M T
- Isaacs, C
- Swain, S M
Producer: 20191114
In:
Breast cancer research and treatment vol. 175
Availability: No items available.
|